Medical News

Daily Isoniazid Can Prevent TB in HIV Patients, Study Shows

August 20, 2013

"An inexpensive daily pill can often fend off a lethal bout of tuberculosis [TB] in people with HIV, according to a large new study," the New York Times reports. "The study, published last week by Lancet Infectious Diseases, found that a daily isoniazid pill reduced deaths and active TB cases by 31 percent among 12,816 patients at 29 Brazilian clinics," the newspaper writes, adding that among patients who took their pills, determined through urine testing, "the effect was far greater." Side effects of the drug were minor and no patients who developed TB showed signs of drug resistance, the newspaper notes. "An editorial accompanying the study looked at several isoniazid trials and said the antibiotic worked, but only when public clinics could test patients correctly, provide pills steadily and make sure they were taken," the New York Times writes (McNeil, 8/19).

Back to other news for August 2013

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.